Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada

Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Eleni Galanis, Monika Naus, David M Patrick, Hind Sbihi, Shiraz El Adam, Bonnie Henry, Linda M N Hoang, Manish Sadarangani, Agatha N Jassem, Mel Krajden
doi: https://doi.org/10.1101/2021.06.07.21258332

Data Availability

To the extent they comply with relevant privacy legislation, data sharing will be considered upon request.

Back to top
Posted June 09, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including P.1 and B.1.1.7 variants: a test-negative design in adults 70 years and older in British Columbia, Canada
Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Eleni Galanis, Monika Naus, David M Patrick, Hind Sbihi, Shiraz El Adam, Bonnie Henry, Linda M N Hoang, Manish Sadarangani, Agatha N Jassem, Mel Krajden
medRxiv 2021.06.07.21258332; doi: https://doi.org/10.1101/2021.06.07.21258332
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area